Quanta Lite Rna Pol Iii Elisa
Autoantibodies, Anti-Ribonucleic Acid Polymerase (Rnap) Iii Antibody. 510(k) K070066, from Inova Diagnostics, Inc. (San Diego, CA). Product code NYO, class 2.
As of Nov 20, 2026, K070066 is an FDA 510(k) held by Inova Diagnostics, Inc., substantially equivalent on Apr 11, 2007 after 93 days, with no recalls tied to it in FDA's recall database.
- Review time: 93 days
- Recalls: 0
- Cited as a predicate by: 1 device
The QUANTA Lite™ RNA Pol III ELISA is a semiquantitative enzyme-linked immunosorbent assay for the detection of IgG anti-RNA Polymerase III antibodies in patient sera. The presence of these antibodies, when considered in conjunction with other laboratory and clinical findings, is an aid in the diagnosis of systemic sclerosis (scleroderma) with increased incidence of skin involvement and renal…
- EliA RNA Pol IIIK202541 · Phadia AB · Sep 13, 2021
- EliA RNA Pol IIIK202541 · Phadia AB · Sep 13, 2021
- Type
- Traditional
- Received
- Jan 8, 2007
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files